Article No
M096-3
Application | FC, IP |
Article No | M096-3 |
Country Availability | SE, FI, DK, NO, IS, EE, LV, LT, FO, GL |
Clone | 8D2 |
Clone Type | monoclonal |
Concentration | 1 mg/mL |
Conjugation | Unconjugated |
Description | Anti-CD170 (Siglec-5) (Mouse) mAb |
Supplier | MBL |
Immunogen | L cells transfected with mouse CD170 |
Isotype | IgG2b |
Notes | SiglecE (sialic acid-binding immunoglobulin-like lectin E/SigLec5/CD170) is a putative adhesion molecule that mediates sialic-acid dependent binding to cells. SiglecE is expressed on neutrophil and monocyte populations, both in the blood and bone marrow, as a dimeric, disulfide linked, 140 kDa type I membrane protein containing cytoplasmic immune receptor-based tyrosine signaling motifs. SiglecE recruits the SH2-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2, which block signal transduction through dephosphorylation of signaling molecules. Thus SiglecE acts as an inhibitory receptor for ligand induced tyrosine phosphorylation. |
Product Type | Antibodies Primary |
Shipping Information | 4°C |
Size | 100 µg |
Source / Host | rat |
Species Reactivity | mouse |
Stability | 1 year |
Storage | -20°C |
Substrate / Buffer | 100 μg IgG in 100 μl PBS containing 50% glycerol, pH 7.2. Contains no preservatives. |
Technical Specifications | SiglecE (sialic acid-binding immunoglobulin-like lectin E/SigLec5/CD170) is a putative adhesion molecule that mediates sialic-acid dependent binding to cells. SiglecE is expressed on neutrophil and monocyte populations, both in the blood and bone marrow, as a dimeric, disulfide linked, 140 kDa type I membrane protein containing cytoplasmic immune receptor-based tyrosine signaling motifs. SiglecE recruits the SH2-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2, which block signal transduction through dephosphorylation of signaling molecules. Thus SiglecE acts as an inhibitory receptor for ligand induced tyrosine phosphorylation. |
Product Page Updated | 2023-12-29T16:20:16.638Z |